Since the establishment of Bioibérica in 1975, the company has specialized in research, manufacturing and marketing of biomolecules for the pharmaceutical and veterinary industry. It is currently a leader in Chondroprotection and the world’s largest manufacturer of glycosaminoglycans such as Chondroitin Sulfate, Glucosamine, Hyaluronic Acid and Heparin.

Bioibérica provides solutions in the management of osteoarthritis, offering a service that aims to help veterinarians to perform a better job in their daily clinical practice.